StockWatch
·

Mahamaya Lifesciences Ltd Q2 FY26 Results

MAHALIFEQ2 FY26 Results
Filing
MetricValue ( Cr)Q2 FY25
Revenue163.060.0%
Total Income164.330.0%
Expenditure152.760.0%
PBT11.570.0%
Net Profit8.530.1%
OPM3.28%3.82pp
NPM5.19%0.04pp
EPS4.80
View full financials

Informational and educational content only. Not investment advice.